18-Fluorodeoxyglucose positron emission tomography/computed tomography in the management of aggressive non-Hodgkin's B-cell lymphoma

Simple item page
dc.contributor.authorShelly, M. J.
dc.contributor.authorMcDermott, S.
dc.contributor.authorO'Connor, Owen J.
dc.contributor.authorBlake, M. A.
dc.date.accessioned2016-07-13T13:29:51Z
dc.date.available2016-07-13T13:29:51Z
dc.date.issued2012
dc.date.updated2012-09-26T15:26:16Z
dc.description.abstract18-Fluorodeoxyglucose (FDG-PET/CT) is an established imaging modality that has been proven to be of benefit in the management of aggressive B-cell non-Hodgkin's lymphoma, such as diffuse large B-cell lymphoma and advanced stage follicular lymphoma. The combination of anatomic and functional imaging afforded by FDG-PET/CT has led to superior sensitivity and specificity in the primary staging, restaging, and assessment of response to treatment of hematological malignancies when compared to FDG-PET and CT alone. The use of FDG-PET/CT for post treatment surveillance imaging remains controversial, and further study is needed to ascertain whether this modality is cost effective and appropriate for use in this setting.en
dc.description.statusNot peer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleid456706
dc.identifier.articleid
dc.identifier.citationShelly, M. J., McDermott S., O'Connor O. J. and Blake M. A. (2012) '18-Fluorodeoxyglucose positron emission tomography/computed tomography in the management of aggressive non-Hodgkin's B-cell lymphoma', ISRN Hematology, 456706. http://dx.doi.org/10.5402/2012/456706en
dc.identifier.doi10.5402/2012/456706
dc.identifier.endpage456706 (9)en
dc.identifier.issn2090-441X
dc.identifier.issn2090-4428
dc.identifier.journaltitleIRSN Hematologyen
dc.identifier.startpage456706 (1)en
dc.identifier.urihttps://hdl.handle.net/10468/2869
dc.language.isoenen
dc.publisherHindawi Publishing Corporationen
dc.rights© 2012 M. J. Shelly et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/en
dc.subjectLymphomaen
dc.subjectFDG-PET/CTen
dc.subjectFluorodeoxyglucoseen
dc.subjectNon-Hodgkin's lymphomaen
dc.title18-Fluorodeoxyglucose positron emission tomography/computed tomography in the management of aggressive non-Hodgkin's B-cell lymphomaen
dc.typeArticle (non peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
FDG_IN_AGGRESSIVE_NHL_ISRN.HEMATOLOGY2012-456706.pdf
Size:
1.12 MB
Format:
Adobe Portable Document Format
Description:
Published Version
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medicine - Journal Articles